TR200100331T2 - Kamptotesin türevlerinin az bir gastrointestinal toksisite ile kullanımı - Google Patents

Kamptotesin türevlerinin az bir gastrointestinal toksisite ile kullanımı

Info

Publication number
TR200100331T2
TR200100331T2 TR2001/00331T TR200100331T TR200100331T2 TR 200100331 T2 TR200100331 T2 TR 200100331T2 TR 2001/00331 T TR2001/00331 T TR 2001/00331T TR 200100331 T TR200100331 T TR 200100331T TR 200100331 T2 TR200100331 T2 TR 200100331T2
Authority
TR
Turkey
Prior art keywords
camptothecin derivatives
gastrointestinal toxicity
little
little gastrointestinal
gastro
Prior art date
Application number
TR2001/00331T
Other languages
English (en)
Inventor
Toutain Herve
Guffroy Magali
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9810043A external-priority patent/FR2782009B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of TR200100331T2 publication Critical patent/TR200100331T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Gastro-intestinal yollarinin asgari düzeyde yan etkilere maruz kalmasina sebebiyet verecek sekilde, gastro-intestinal yollarin kanserlerinin tedavisine yönelik ilaçlarin hazirlanmasi için kamptotesin kurüvlerinin kullanilmasi olup, sözü geçen ilacin uygulanmasi esnasinda veya böyle bir uygulamadan önce ve böyle bir uygulama esnasinda bir sodyum klorür solüsyonunun uygulanmasi ile tanimlanir.
TR2001/00331T 1998-08-05 1999-08-03 Kamptotesin türevlerinin az bir gastrointestinal toksisite ile kullanımı TR200100331T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9810043A FR2782009B1 (fr) 1998-08-05 1998-08-05 Utilisation de derives de la comptothecine, avec une toxicite gastro-intestinale reduite
US9631898P 1998-08-12 1998-08-12

Publications (1)

Publication Number Publication Date
TR200100331T2 true TR200100331T2 (tr) 2001-07-23

Family

ID=26234482

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00331T TR200100331T2 (tr) 1998-08-05 1999-08-03 Kamptotesin türevlerinin az bir gastrointestinal toksisite ile kullanımı

Country Status (24)

Country Link
US (1) US6476043B1 (tr)
EP (1) EP1102594B1 (tr)
JP (1) JP2002522392A (tr)
KR (1) KR20010072228A (tr)
AT (1) ATE217531T1 (tr)
AU (1) AU771195B2 (tr)
BG (1) BG64641B1 (tr)
CA (1) CA2340020A1 (tr)
CZ (1) CZ295775B6 (tr)
DE (1) DE69901506T2 (tr)
DK (1) DK1102594T3 (tr)
EA (1) EA002917B1 (tr)
EE (1) EE04264B1 (tr)
ES (1) ES2176009T3 (tr)
GE (1) GEP20043254B (tr)
HU (1) HUP0103314A3 (tr)
ID (1) ID27253A (tr)
IL (1) IL141232A0 (tr)
NO (1) NO20010454L (tr)
NZ (1) NZ509859A (tr)
PT (1) PT1102594E (tr)
SK (1) SK1732001A3 (tr)
TR (1) TR200100331T2 (tr)
WO (1) WO2000007605A1 (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60030283T2 (de) 1999-05-17 2007-09-20 Cancer Research Ventures Ltd. Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen
CA2295429A1 (en) * 2000-01-06 2001-07-06 Michael Michael Treatment or prevention of diarrhea
DE602005024923D1 (de) * 2004-02-13 2011-01-05 Yakult Honsha Kk Wässrige lösung mit einem camptothecin
US20050197355A1 (en) * 2004-03-02 2005-09-08 Henegar Kevin E. Compounds useful in preparing camptothecin derivatives
US20070207149A1 (en) 2004-04-27 2007-09-06 Wellstat Biologics Corporation Cancer treatment using viruses and camptothecins
JP2006151950A (ja) * 2004-11-05 2006-06-15 Oto Corporation:Kk 納豆菌培養エキス含有製剤及び納豆菌培養エキスの保存方法
WO2006082279A1 (en) * 2005-02-07 2006-08-10 Fermion Oy Process for the manufacturing of 7-ethyl-10-hydroxy camptothecin
CA2591071C (en) * 2005-02-08 2014-04-29 Fermion Oy Process for producing [1,4'] bipiperidinyl-1'-carbonyl chloride or hydrochloride thereof
PL1928883T3 (pl) * 2005-02-08 2014-03-31 Fermion Oy Sposób otrzymywania chlorowodorku irynotekanu
US7994186B2 (en) * 2005-04-18 2011-08-09 Kabushiki Kaisha Yakult Honsha Pharmaceutical compositions containing camptothecins
US7767200B2 (en) 2005-07-14 2010-08-03 Wellstat Biologics Corporation Cancer treatment using viruses, fluoropyrimidines and camptothecins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284579A (en) * 1979-07-17 1981-08-18 The United States Of America As Represented By The Of The Department Of Health & Human Services (N-Phosphonacetyl-L-aspartato)(1,2-diaminocyclchexane)platinum(II) or alkali metal salt
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
JPS58154582A (ja) * 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
JPS6019790A (ja) * 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
CH663353A5 (de) * 1984-03-28 1987-12-15 Joaquin Amat Larraz Mittel gegen krebs.
CA1332413C (en) * 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
US5225404A (en) 1989-11-06 1993-07-06 New York University Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
IT1247937B (it) * 1991-05-16 1995-01-05 Ist Naz Ric Sul Cancro Associazione farmaceutica ad attivita' antineoplastica
JP3359955B2 (ja) * 1992-07-16 2002-12-24 第一製薬株式会社 抗腫瘍剤
AU3684395A (en) 1994-10-06 1996-05-02 Leon T. Atlas Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases

Also Published As

Publication number Publication date
GEP20043254B (en) 2004-06-25
US6476043B1 (en) 2002-11-05
DE69901506T2 (de) 2002-11-28
DE69901506D1 (de) 2002-06-20
NO20010454D0 (no) 2001-01-26
CZ295775B6 (cs) 2005-11-16
AU5168799A (en) 2000-02-28
ID27253A (id) 2001-03-22
KR20010072228A (ko) 2001-07-31
BG64641B1 (bg) 2005-10-31
EE04264B1 (et) 2004-04-15
HUP0103314A2 (hu) 2002-01-28
WO2000007605A1 (fr) 2000-02-17
EP1102594B1 (fr) 2002-05-15
NO20010454L (no) 2001-01-26
AU771195B2 (en) 2004-03-18
DK1102594T3 (da) 2002-08-26
ATE217531T1 (de) 2002-06-15
EE200100066A (et) 2002-06-17
ES2176009T3 (es) 2002-11-16
JP2002522392A (ja) 2002-07-23
CZ2001382A3 (en) 2001-05-16
EP1102594A1 (fr) 2001-05-30
IL141232A0 (en) 2002-03-10
CA2340020A1 (fr) 2000-02-17
EA200100214A1 (ru) 2001-08-27
HUP0103314A3 (en) 2002-07-29
NZ509859A (en) 2003-09-26
EA002917B1 (ru) 2002-10-31
SK1732001A3 (en) 2001-06-11
PT1102594E (pt) 2002-10-31
BG105216A (en) 2001-10-31

Similar Documents

Publication Publication Date Title
TR200102603T2 (tr) Antitümör aktiviteye sahip olan kamptotesin türevleri
TR200100331T2 (tr) Kamptotesin türevlerinin az bir gastrointestinal toksisite ile kullanımı
BR0207378A (pt) Tratamento de câncer
ES2249888T3 (es) Conjugados de paclitaxel solubles en agua, combinados con irradiacion para el tratamiento del cancer.
TR200200717T2 (tr) Terapötik kinazolin türevleri.
DE69834923D1 (en) Hochgradig lipophile camptothecin-derivate
DE60131177D1 (de) Abbaubare polyacetal-polymere
DE3752123D1 (de) Derivate des physiologisch aktiven mittels k-252
BR0009770A (pt) Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma
TR200003879T2 (tr) İn vivo ışın tedavisine duyarlılaştırıcı özelliklere sahip farnesil protein transferaz inhibitörleri@
TR200000223T2 (tr) XA faktörünü engelleyen heterosiklik türevler
TR200101633T2 (tr) Farmasötik bileşim
BR0115162A (pt) Tratamentos antitumorais eficazes
TR199900336T2 (tr) EAA antagonistleri olarak tetrahidrokinolin türevleri.
CY1105803T1 (el) Συνθεση πepιλαμβανουσα καμπτοθεκινη και ενα παραγωγο πυριμιδινης για τη θepαπεια καρκινου
TR200002099A3 (tr) Siklobüten türevleri, bunlarin hazirlanmasi ve terapötik kullanimlari
AR043071A1 (es) Uso de macrolidos para el tratamiento del cancer y degeneracion macular y una composicion farmaceutica
CY1106449T1 (el) Βελτιωμενη μεθοδος για εκριζωση του helicobacter pylori
EE03771B1 (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
TR200002120A3 (tr) Heteroaril-Ikameli Pirrol Türevleri, Bunlarin Hazirlanmasi ve Bunlarin Terapötik Kullanimlari
NO20031410D0 (no) Antitumorterapi innbefattende distamycinderivater
YU5301A (sh) Primena derivata kamptotecina sa smanjenom gastro-intestinalnom toksičnošću
RU97110400A (ru) Способ профилактики и лечения больных, страдающих эстрогенно- и андрогенозависимыми опухолями
TH10441B (th) การใช้อนุพันธ์เพรคเนม
RU93030807A (ru) Диоксадэт - средство для лечения онкологических больных